Stefanus Christian 22010111120009 Lap.KTI BAB 8
DAFTAR PUSTAKA
1.
Pokja Infeksi Perhimpunan Dokter Paru Indonesia. Pneumonia Komunitas:
Pedoman Diagnosis dan Penatalaksanaan Di Indonesia. 2003
2.
Bartlett JG, Scott F, Dowell, Lionel A, Mandell, et al. Practice Guidelines for
the Management of Community-Acquired Pneumonia in Adults. Clinical
Infectious Diseases. 2000; 31: 347–82
3.
South East Asian Medical Information Center. Seamic health statistics 2000.
2001
4.
Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, et al.
Epidemiology and outcome of severe pneumococcal pneumonia admitted to
intensive care unit: a multicenter study. Critical care. 2012; 16(4): R155
5.
WHO.
Pneumonia.
2014.
Available
from:
www.who.int/mediacentre/factsheets/fs331/en/
6.
Musher DM, Anna R. Thorner. Community-Acquired Pneumonia. The New
England Journal Of Medicine. 2014: 371; 17
7.
File TM. Community-Acquired Pneumonia. Lancet. 2003: 362; 1991
8.
Brown JS. Community-Acquired Pneumonia. Clinical Medicine 2012, Vol
12, No 6: 538–543
9.
Dharmadhikari V, Joseph T, Kulkarni A. Bacteriological and Clinical Profile
of Community Acquired Pneumonia in Hospitalized Patients. International
Journal of Pharma and Bio Sciences. 2013: 695–702
10. Farida H, Juliëtte A. Severin, M. Gasem MH, et al. Nasopharyngeal Carriage
of Klebsiella pneumoniae and Other Gram-Negative Bacilli in PneumoniaProne Age Groups in Semarang, Indonesia. Journal of Clinical Microbiology.
2013: 1614–1616
11. Lim WS, Eerden MM, Laing R, et al. Defining community acquired
pneumonia severity on presentation to hospital: an international derivation
and validation study. Thorax. 2003; 58: 377–382
48
49
12. Lawrence MT, McPhee JS, Papadakis AM. Diagnosis dan Terapi Kedokteran
Penyakit Dalam. 1 ed. Jakarta: Salemba Medika; 2002. 100 - 10 p
13. Armitage K, Woodhead M. New guidelines for the management of adult
community-acquired pneumonia. Current opinion in infectious diseases.
2007; 20(2): 170-6
14. Dahlan Z. Chapter Pneumonia in Buku Ajar Penyakit Dalam jilid II Edisi IV.
Jakarta: Interna Publishing: 2014. 1608-1619
15. WHO.
Pneumonia.
2014.
Available
from:
who.int/mediacentre/factsheets/fs310/en/
16. Mendel LA, Wuderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC,
Dowell SF, et al. Infectious Disease Society Of America / American Thoracic
Society Consensus Guidelines On The Management Of Community-Acquired
Pneumonia In Adults. Clinical Infectious Disease. 2007; 44: 527-72
17. Ewig S, Welte T. Evaluation of guidelines for community-acquired
pneumonia: a story of confounders, surprises and challenges. Eur Respir J.
2008; 32: 823-5
18. Rabbat A, Huchon GJ. Bacterial Pneumonia. Dalam: Albert RK, Spiro SG,
Jett JR, Clinical Respiratory Medicine, second edition. Ontario: Mosby. 2004;
23: 273-287
19. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C.
Infectious Diseases Society of America. Update of practice guidelines for the
management of community-acquired pneumonia in immunocompetent adults.
Clin Infect Dis. 2003; 37: 1405-1433
20. CDC. The Pink Book: Course Textbook - 12th Edition Second Printing. May
2012. Available from: cdc.gov/vaccines/pubs/pinkbook/pneumo.html
21. Lim WS, Macfarlane JT, Boswell TCJ, Harrison TG, Rose D, Leinonen M,
Saikku P. Study of community acquired pneumonia aetiology (SCAPA) in
adults admitted to hospital: implication for management guidelines. Thorax
2001; 56: 296 – 301
50
22. Sharpe BA, Flanders SA. Community Acquired Pneumonia: A practical
approach to management for hospital. Journal of Hospital Medicine vol 1, no
3. 2006; 177-190
23. Mandell LA. Pneumonia, In : Fauci AS, Kasper DL, Longo DL, eds,
Harrison’s Principles of Internal Medicine, 17th ed, USA, The Mc Graw- Hill
companies Inc. 2008; chapter 251
24. Sharma S, Maycher Bruce, Eschun Gregg. Radiological Imaging in
Pneumonia. Recent Innovations Imaging of Bacterial Pneumonia; 2014.
Available from: medscape.org/viewarticle/556344_2
25. Boersma WG, Daniels J, Löwenberg A, Boeve W-J, van de Jagt EJ.
Reliability of radiographic findings and the relation to etiologic agents in
community-acquired pneumonia. Respiratory medicine. 2006; 100(5): 92632
26. Mandell LA, Wunderink R. Pneumonia. Harrison's Principles of Internal
Medicine. 2. 18th Edition ed. Jakarta: Penerbit Buku Kedokteran EGC. 2006.
957 – 90 p
27. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al.
A prediction rule to identify low-risk patients with community-acquired
pneumonia.N Engl J Med 1997; 336: 243–50
28. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell
GD, et al; American Thoracic Society. Guidelines for the management of
adults with community-acquired pneumonia: Diagnosis, assessment of
severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med.
2001; 163: 1730-1754.
29. Blot SI, Rodriguez A, Solé-Violán, J, Blanquer J, Almirall J, and Rello J.
Effects of delayed oxygenation assessment on time to antibiotic delivery and
mortality in patients with severe community-acquired pneumonia. Crit Care
Med 2007; 35: 2509–2514
30. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al.
BTS guidelines for the management of community acquired pneumonia in
51
adults: update 2009. Thorax 2009; 64: iii1- iii55 doi: 10.1136/thx. 2009.
121434
31. Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in communityacquired pneumonia. Mineola. American Journal of Nephrology. 2007;
27(2):184-190
32. Prasad R. Community Acquired Pneumonia: Clinical Manifestations. Uttar
Pradesh. Supplement to JAPI 2012 VOL. 60: 10
33. Yamakawa S, et al. Recurrent Pneumonia with Unconsciousness. Yokohama,
Japan. Journal of Internal Medicine 2002; 251: 278-279
34. Wyss M, Daouk RK. Creatine and Creatinine Metabolism. Massachusetts.
Physiological Reviews Vol. 80, No. 3, July 2000: 1114
35. Khan FY, Sayed H. Rhabdomyolysis associated with Mycoplasma
pneumoniae pneumonia. Doha, Qatar. Hong Kong Med J Vol 18 No 3, June
2012: 247-248
36. Blanco RJ, Zabalza M, Salcedo J, Roman SJ. Rhabdomyolysis as a results of
Streptococcus pneumoniae: report of a case and review. Spain. European
Society of Clinical Microbiology and Infectious Diseases 2003 : 944-947
37. Mortron SE, Mathai M, Byrd RP, Fields CL, Toy TM. Influenza a Pneumonia
with Rhabdomyolysis. Johnson City. South Med J. 2001; 94 (1)
38. Garcia MC, Ebeo CT, Byrd RP Jr, Roy TM. Rhabdomyolysis associated with
pneumococcal pneumonia: an early clinical indicator of increased morbidity?.
Mountain Home. Tenn Med 2002 Feb; 95(2): 67-9.
39. Ali A, El S, Sikka P, Ramadan F, Davies J. Etiology of Severe Pneumonia in
the Very Elderly. American Journal of Respiratory and Critical Care
Medicine, Vol. 163, No. 3 (2001), pp. 645-651
52
LAMPIRAN
Lampiran 1. Biodata Penulis
1. Identitas
Nama
: Stefanus Christian Setiawan
NIM
: 22010111120009
Tempat/tanggal lahir : Semarang, 18 Desember 1993
Jenis kelamin
: Laki-Laki
Alamat
: Jl. Kenconowungu 6 / 37, Semarang
Nomor HP
: 081227007702
E-mail
: stchristians@yahoo.com
2. Riwayat Pendidikan Formal
1. SD
: SD YSKI
Lulus tahun
: 2005
2. SMP
: SMP Domenico Savio
Lulus Tahun
: 2008
3. SMA
: SMA Karangturi
Lulus Tahun
: 2011
4. FK UNDIP
: Masuk Tahun 2011
3. Keanggotaan Organisasi
1. Sie. Perkap Porseni FK UNDIP 2013
2. Sie. P&K PMKK FK UNDIP 2011-2012
3. Wakil Ketua Kemah Bakti FK UNDIP 2014
53
Lampiran 2. Ethical Clearance
54
Lampiran 3. Kuisioner CAPSIN
55
Lampiran 4. Analisis Data SPSS
Crosstabs
Jenis kelamin * Outcome
Crosstab
Jenis kelamin
P
W
Total
Count
% within Jenis kelamin
Count
% within Jenis kelamin
Count
% within Jenis kelamin
Outcome
Mati
Sembuh
17
43
28.3%
71.7%
21
52
28.8%
71.2%
38
95
28.6%
71.4%
Usia * Outcome
Crosstab
Usia
15-24
25-34
35-44
45-54
55-64
>= 65
Total
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Outcome
Mati
Sembuh
0
10
.0%
100.0%
3
5
37.5%
62.5%
4
14
22.2%
77.8%
7
15
31.8%
68.2%
11
18
37.9%
62.1%
13
33
28.3%
71.7%
38
95
28.6%
71.4%
Total
10
100.0%
8
100.0%
18
100.0%
22
100.0%
29
100.0%
46
100.0%
133
100.0%
Total
60
100.0%
73
100.0%
133
100.0%
56
Demam * Outcome
Crosstab
Demam
Ya
Tidak
Total
Outcome
Mati
Sembuh
34
83
29.1%
70.9%
4
12
25.0%
75.0%
38
95
28.6%
71.4%
Count
% within Demam
Count
% within Demam
Count
% within Demam
Total
117
100.0%
16
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.114b
.002
.116
.113
df
1
1
1
Asymp. Sig.
(2-sided)
.736
.966
.733
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.497
.737
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
4.57.
Risk Estimate
Value
Odds Ratio for
Demam (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.229
.370
4.080
1.162
.475
2.844
.946
.697
1.284
133
57
Sakit kepala * Outcome
Crosstab
Sakit kepala
Ya
Tidak
Total
Outcome
Mati
Sembuh
9
29
23.7%
76.3%
29
66
30.5%
69.5%
38
95
28.6%
71.4%
Count
% within Sakit kepala
Count
% within Sakit kepala
Count
% within Sakit kepala
Total
38
100.0%
95
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.623b
.333
.637
.618
df
1
1
1
Asymp. Sig.
(2-sided)
.430
.564
.425
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.526
.285
.432
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
10.86.
Risk Estimate
Value
Odds Ratio for Sakit
kepala (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.706
.297
1.679
.776
.407
1.481
1.098
.880
1.371
133
58
Chill * Outcome
Crosstab
Chill
Ya
Tidak
Total
Count
% within Chill
Count
% within Chill
Count
% within Chill
Outcome
Mati
Sembuh
7
21
25.0%
75.0%
31
74
29.5%
70.5%
38
95
28.6%
71.4%
Total
28
100.0%
105
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.222b
.055
.226
.220
df
1
1
1
Asymp. Sig.
(2-sided)
.638
.814
.634
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.814
.415
.639
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
8.00.
Risk Estimate
Value
Odds Ratio for Chill
(Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.796
.307
2.063
.847
.418
1.716
1.064
.831
1.362
133
59
Batuk * Outcome
Crosstab
Batuk
Ya
Tidak
Total
Outcome
Mati
Sembuh
36
89
28.8%
71.2%
2
6
25.0%
75.0%
38
95
28.6%
71.4%
Count
% within Batuk
Count
% within Batuk
Count
% within Batuk
Total
125
100.0%
8
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.053b
.000
.055
.053
df
1
1
1
Asymp. Sig.
(2-sided)
.818
1.000
.815
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.588
.818
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
2.29.
Risk Estimate
Value
Odds Ratio for
Batuk (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.213
.234
6.296
1.152
.336
3.947
.949
.627
1.438
133
60
Sputum * Outcome
Crosstab
Sputum
Ya
Tidak
Total
Count
% within Sputum
Count
% within Sputum
Count
% within Sputum
Outcome
Mati
Sembuh
25
66
27.5%
72.5%
13
29
31.0%
69.0%
38
95
28.6%
71.4%
Total
91
100.0%
42
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.171b
.043
.169
.169
df
1
1
1
Asymp. Sig.
(2-sided)
.680
.836
.681
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.685
.414
.681
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
12.00.
Risk Estimate
Value
Odds Ratio for
Sputum (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.845
.380
1.880
.888
.506
1.556
1.050
.827
1.334
133
61
Hemoptysis * Outcome
Crosstab
Hemoptysis
Ya
Tidak
Total
Outcome
Mati
Sembuh
0
12
.0%
100.0%
38
83
31.4%
68.6%
38
95
28.6%
71.4%
Count
% within Hemoptysis
Count
% within Hemoptysis
Count
% within Hemoptysis
Total
12
100.0%
121
100.0%
133
100.0%
Chi-Square Tests
Value
5.276 b
3.849
8.542
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
5.236
df
1
1
1
Asymp. Sig.
(2-sided)
.022
.050
.003
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.019
.014
.022
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
3.43.
Risk Estimate
Value
For cohort Outcome
= Sembuh
N of Valid Cases
Dyspnea * Outcome
1.458
133
95% Confidence
Interval
Lower
Upper
1.292
1.645
62
Crosstab
Dyspnea
Ya
Outcome
Mati
Sembuh
38
80
32.2%
67.8%
0
15
.0%
100.0%
38
95
28.6%
71.4%
Count
% within Dyspnea
Count
% within Dyspnea
Count
% within Dyspnea
Tidak
Total
Total
118
100.0%
15
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
6.763 b
5.277
10.839
df
1
1
1
6.712
Asymp. Sig.
(2-sided)
.009
.022
.001
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.006
.005
.010
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
4.29.
Risk Estimate
Value
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.678
.599
.768
133
Pleuric pain * Outcome
Crosstab
Pleuric
pain
Ya
Tidak
Total
Count
% within Pleuric pain
Count
% within Pleuric pain
Count
% within Pleuric pain
Outcome
Mati
Sembuh
1
6
14.3%
85.7%
37
89
29.4%
70.6%
38
95
28.6%
71.4%
Total
7
100.0%
126
100.0%
133
100.0%
63
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.739b
.185
.840
df
1
1
1
.733
Asymp. Sig.
(2-sided)
.390
.667
.359
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.673
.354
.392
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
2.00.
Risk Estimate
Value
Odds Ratio for Pleuric
pain (Ya / Tidak)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.401
.047
3.447
.486
.078
3.047
1.213
.879
1.676
133
Penurunan kesadaran * Outcome
Crosstab
Penurunan
kesadaran
Ya
Tidak
Total
Count
% within Penurunan
kesadaran
Count
% within Penurunan
kesadaran
Count
% within Penurunan
kesadaran
Outcome
Mati
Sembuh
17
10
Total
27
63.0%
37.0%
100.0%
21
85
106
19.8%
80.2%
100.0%
38
95
133
28.6%
71.4%
100.0%
64
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
19.634b
17.576
18.017
df
1
1
1
19.486
1
Asymp. Sig.
(2-sided)
.000
.000
.000
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.000
.000
.000
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
7.71.
Risk Estimate
Value
Odds Ratio for
Penurunan kesadaran
(Ya / Tidak)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
6.881
2.754
17.190
3.178
1.967
5.136
.462
.280
.762
133
Profil klinik * Outcome
Crosstab
Profil
klinik
1-3
4-6
6-9
Total
Count
% within Profil klinik
Count
% within Profil klinik
Count
% within Profil klinik
Count
% within Profil klinik
Outcome
Mati
Sembuh
7
25
21.9%
78.1%
31
68
31.3%
68.7%
0
2
.0%
100.0%
38
95
28.6%
71.4%
Total
32
100.0%
99
100.0%
2
100.0%
133
100.0%
65
Chi-Square Tests
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value
1.868 a
2.446
2
2
Asymp. Sig.
(2-sided)
.393
.294
1
.507
df
.441
133
a. 2 cells (33.3%) have expected count less than 5. The
minimum expected count is .57.
Hemoglobin * Outcome
Crosstab
Hemoglobin
Tidak
Normal
Total
Count
% within Hemoglobin
Count
% within Hemoglobin
Count
% within Hemoglobin
Outcome
Mati
Sembuh
25
66
27.5%
72.5%
13
29
31.0%
69.0%
38
95
28.6%
71.4%
Total
91
100.0%
42
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.171b
.043
.169
.169
df
1
1
1
1
Asymp. Sig.
(2-sided)
.680
.836
.681
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.685
.414
.681
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
12.00.
66
Risk Estimate
Value
Odds Ratio for
Hemoglobin (Tidak /
Normal)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.845
.380
1.880
.888
.506
1.556
1.050
.827
1.334
133
Hematokrit * Outcome
Crosstab
Hematokrit
Tidak
Normal
Total
Outcome
Mati
Sembuh
24
61
28.2%
71.8%
14
34
29.2%
70.8%
38
95
28.6%
71.4%
Count
% within Hematokrit
Count
% within Hematokrit
Count
% within Hematokrit
Total
85
100.0%
48
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.013b
.000
.013
.013
df
1
1
1
1
Asymp. Sig.
(2-sided)
.909
1.000
.909
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.531
.909
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.71.
67
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Hematokrit
(Tidak / Normal)
For cohort Outcome = Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.956
.437
2.087
.968
.555
1.688
1.013
.809
1.269
133
Eritrosit * Outcome
Crosstab
Eritrosit
Tidak
Normal
Total
Outcome
Mati
Sembuh
18
54
25.0%
75.0%
20
33
37.7%
62.3%
38
87
30.4%
69.6%
Count
% within Eritrosit
Count
% within Eritrosit
Count
% within Eritrosit
Total
72
100.0%
53
100.0%
125
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
2.340 b
1.777
2.325
2.322
df
1
1
1
1
Asymp. Sig.
(2-sided)
.126
.183
.127
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.168
.092
.128
125
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
16.11.
68
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Eritrosit
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.550
.255
1.188
.663
.390
1.124
1.205
.940
1.544
125
Lekosit * Outcome
Crosstab
Lekosit
Tidak
Normal
Total
Outcome
Mati
Sembuh
26
67
28.0%
72.0%
12
28
30.0%
70.0%
38
95
28.6%
71.4%
Count
% within Lekosit
Count
% within Lekosit
Count
% within Lekosit
Total
93
100.0%
40
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.057b
.001
.057
.057
df
1
1
1
1
Asymp. Sig.
(2-sided)
.811
.976
.811
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.836
.483
.812
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
11.43.
69
Risk Estimate
Value
Odds Ratio for Lekosit
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.905
.401
2.043
.932
.524
1.656
1.029
.810
1.307
133
Trombosit * Outcome
Crosstab
Trombosit
Tidak
Normal
Total
Outcome
Mati
Sembuh
20
44
31.3%
68.8%
18
51
26.1%
73.9%
38
95
28.6%
71.4%
Count
% within Trombosit
Count
% within Trombosit
Count
% within Trombosit
Total
64
100.0%
69
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.434b
.218
.434
.430
df
1
1
1
1
Asymp. Sig.
(2-sided)
.510
.641
.510
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.567
.320
.512
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
18.29.
70
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Trombosit
(Tidak / Normal)
For cohort Outcome = Mati
1.288
.606
2.737
1.198
.699
2.052
.930
.749
1.155
For cohort Outcome =
Sembuh
N of Valid Cases
133
Ureum * Outcome
Crosstab
Ureum
Tidak
Normal
Total
Outcome
Mati
Sembuh
28
57
32.9%
67.1%
10
38
20.8%
79.2%
38
95
28.6%
71.4%
Count
% within Ureum
Count
% within Ureum
Count
% within Ureum
Total
85
100.0%
48
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
2.204 b
1.650
2.273
2.187
df
1
1
1
1
Asymp. Sig.
(2-sided)
.138
.199
.132
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.164
.098
.139
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.71.
71
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Ureum
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
1.867
.814
4.283
1.581
.843
2.967
.847
.688
1.043
133
Kreatinin * Outcome
Crosstab
Kreatinin
Tidak
Normal
Total
Outcome
Mati
Sembuh
21
26
44.7%
55.3%
17
69
19.8%
80.2%
38
95
28.6%
71.4%
Count
% within Kreatinin
Count
% within Kreatinin
Count
% within Kreatinin
Total
47
100.0%
86
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
9.243 b
8.062
9.005
9.173
df
1
1
1
1
Asymp. Sig.
(2-sided)
.002
.005
.003
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.004
.002
.002
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.43.
72
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Kreatinin
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
3.278
1.499
7.169
2.260
1.328
3.846
.689
.522
.910
133
GD sewaktu * Outcome
Crosstab
GD sewaktu
Tidak
Normal
Total
Count
% within GD sewaktu
Count
% within GD sewaktu
Count
% within GD sewaktu
Outcome
Mati
Sembuh
12
38
24.0%
76.0%
26
57
31.3%
68.7%
38
95
28.6%
71.4%
Total
50
100.0%
83
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.820b
.501
.833
.814
df
1
1
1
1
Asymp. Sig.
(2-sided)
.365
.479
.361
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.431
.241
.367
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
14.29.
73
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for GD
sewaktu (Tidak / Normal)
For cohort Outcome = Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.692
.312
1.537
.766
.426
1.378
1.107
.894
1.369
133
Natrium * Outcome
Crosstab
Natrium
Tidak
Normal
Total
Outcome
Mati
Sembuh
21
46
31.3%
68.7%
17
49
25.8%
74.2%
38
95
28.6%
71.4%
Count
% within Natrium
Count
% within Natrium
Count
% within Natrium
Total
67
100.0%
66
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.508b
.271
.509
.504
df
1
1
1
1
Asymp. Sig.
(2-sided)
.476
.602
.476
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.566
.301
.478
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
18.86.
74
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Natrium
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
1.316
.618
2.801
1.217
.708
2.092
.925
.746
1.147
133
Kalium * Outcome
Crosstab
Kalium
Tidak
Normal
Total
Outcome
Mati
Sembuh
13
42
23.6%
76.4%
25
53
32.1%
67.9%
38
95
28.6%
71.4%
Count
% within Kalium
Count
% within Kalium
Count
% within Kalium
Total
55
100.0%
78
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
1.119 b
.745
1.134
1.111
df
1
1
1
1
Asymp. Sig.
(2-sided)
.290
.388
.287
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.333
.195
.292
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
15.71.
75
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Kalium
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.656
.300
1.436
.737
.415
1.310
1.124
.909
1.389
133
Khlorida * Outcome
Crosstab
Khlorida
Tidak
Normal
Total
Outcome
Mati
Sembuh
21
32
39.6%
60.4%
17
63
21.3%
78.8%
38
95
28.6%
71.4%
Count
% within Khlorida
Count
% within Khlorida
Count
% within Khlorida
Total
53
100.0%
80
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
5.273 b
4.411
5.206
5.233
df
1
1
1
1
Asymp. Sig.
(2-sided)
.022
.036
.023
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.031
.018
.022
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
15.14.
76
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Khlorida
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
2.432
1.128
5.242
1.865
1.090
3.190
.767
.599
.981
133
Kalsium * Outcome
Crosstab
Kalsium
Tidak
Normal
Total
Outcome
Mati
Sembuh
16
41
28.1%
71.9%
15
34
30.6%
69.4%
31
75
29.2%
70.8%
Count
% within Kalsium
Count
% within Kalsium
Count
% within Kalsium
Total
57
100.0%
49
100.0%
106
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.082b
.005
.082
.082
df
1
1
1
1
Asymp. Sig.
(2-sided)
.774
.942
.774
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.832
.470
.775
106
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
14.33.
77
Risk Estimate
Value
Odds Ratio for Kalsium
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.885
.382
2.046
.917
.507
1.657
1.037
.810
1.327
106
Logistic Regression
Case Processing Summary
Unweighted Cases
Selected Cases
Unselected Cases
Total
a
N
Included in Analysis
Missing Cases
Total
133
0
133
0
133
Percent
100.0
.0
100.0
.0
100.0
a. If weight is in effect, see classification table for the total
number of cases.
78
Dependent Variable Encoding
Original Value
Sembuh
Mati
Internal Value
0
1
Categorical Variables Codings
Khlorida
Dyspnea
Penurunan
kesadaran
Kreatinin
Hemoptysis
Tidak
Normal
Ya
Tidak
Ya
Tidak
Tidak
Normal
Ya
Tidak
Paramete
r coding
(1)
Frequency
53
80
118
15
27
106
47
86
12
121
.000
1.000
.000
1.000
.000
1.000
.000
1.000
.000
1.000
Block 0: Beginning Block
Classification Tablea,b
Predicted
Step 0
Observed
Outcome
Sembuh
Mati
Outcome
Sembuh
Mati
95
0
38
0
Overall Percentage
Percentage
Correct
100.0
.0
71.4
a. Constant is included in the model.
b. The cut value is .500
Variables in the Equation
Step 0
Constant
B
-.916
S.E.
.192
Wald
22.789
df
1
Sig.
.000
Exp(B)
.400
79
Variables not in the Equation
Step
0
Variables
Score
5.276
6.763
19.634
9.243
5.273
33.940
HEMOP(1)
DYSP(1)
TK(1)
KREAT(1)
CHLR(1)
Overall Statistics
df
1
1
1
1
1
5
Sig.
.022
.009
.000
.002
.022
.000
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Step 1
Step
Block
Model
Chi-square
41.355
41.355
41.355
df
5
5
5
Sig.
.000
.000
.000
Model Summary
Step
1
-2 Log
likelihood
117.784
Cox & Snell
R Square
.267
Nagelkerke
R Square
.383
Classification Tablea
Predicted
Step 1
Observed
Outcome
Outcome
Sembuh
Mati
88
7
26
12
Sembuh
Mati
Overall Percentage
Percentage
Correct
92.6
31.6
75.2
a. The cut value is .500
Variables in the Equation
Step
a
1
HEMOP(1)
DYSP(1)
TK(1)
KREAT(1)
CHLR(1)
Constant
B
20.094
-20.128
-1.646
-1.106
-.554
-18.511
S.E.
10479.2
9659.54
.522
.459
.457
10479.2
Wald
.000
.000
9.924
5.810
1.466
.000
df
1
1
1
1
1
1
Sig.
.998
.998
.002
.016
.226
.999
Exp(B)
5.E+08
.000
.193
.331
.575
.000
a. Variable(s) entered on step 1: HEMOP, DYSP, TK, KREAT, CHLR.
95.0% C.I.for
EXP(B)
Lower
Upper
.000
.
.000
.
.069
.537
.135
.813
.235
1.409
80
Logistic Regression
Case Processing Summary
Unweighted Cases
Selected Cases
a
N
Included in Analysis
Missing Cases
Total
133
0
133
0
133
Unselected Cases
Total
Percent
100.0
.0
100.0
.0
100.0
a. If weight is in effect, see classification table for the total
number of cases.
Dependent Variable Encoding
Original Value
Sembuh
Mati
Internal Value
0
1
Categorical Variables Codings
Kreatinin
Penurunan
kesadaran
Tidak
Normal
Ya
Tidak
Frequency
47
86
27
106
Block 0: Beginning Block
Paramete
r coding
(1)
.000
1.000
.000
1.000
81
Classification Tablea,b
Predicted
Step 0
Observed
Outcome
Outcome
Sembuh
Mati
95
0
38
0
Sembuh
Mati
Percentage
Correct
100.0
.0
71.4
Overall Percentage
a. Constant is included in the model.
b. The cut value is .500
Variables in the Equation
Step 0
B
-.916
Constant
S.E.
.192
Wald
22.789
df
1
Sig.
.000
1
1
2
Sig.
.000
.002
.000
Exp(B)
.400
Variables not in the Equation
Step
0
Variables
Score
19.634
9.243
24.938
TK(1)
KREAT(1)
Overall Statistics
df
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Step 1
Step
Block
Model
Chi-square
23.951
23.951
23.951
df
2
2
2
Sig.
.000
.000
.000
Model Summary
Step
1
-2 Log
likelihood
135.188
Cox & Snell
R Square
.165
Nagelkerke
R Square
.236
Classification Tablea
Predicted
Step 1
Observed
Outcome
Overall Percentage
a. The cut value is .500
Sembuh
Mati
Outcome
Sembuh
Mati
85
10
21
17
Percentage
Correct
89.5
44.7
76.7
82
Variables in the Equation
Step
a
1
TK(1)
KREAT(1)
Constant
B
-1.818
-1.042
1.068
S.E.
.481
.428
.474
Wald
14.306
5.918
5.077
a. Variable(s) entered on step 1: TK, KREAT.
df
1
1
1
Sig.
.000
.015
.024
Exp(B)
.162
.353
2.908
95.0% C.I.for EXP(B)
Lower
Upper
.063
.416
.152
.817
1.
Pokja Infeksi Perhimpunan Dokter Paru Indonesia. Pneumonia Komunitas:
Pedoman Diagnosis dan Penatalaksanaan Di Indonesia. 2003
2.
Bartlett JG, Scott F, Dowell, Lionel A, Mandell, et al. Practice Guidelines for
the Management of Community-Acquired Pneumonia in Adults. Clinical
Infectious Diseases. 2000; 31: 347–82
3.
South East Asian Medical Information Center. Seamic health statistics 2000.
2001
4.
Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, et al.
Epidemiology and outcome of severe pneumococcal pneumonia admitted to
intensive care unit: a multicenter study. Critical care. 2012; 16(4): R155
5.
WHO.
Pneumonia.
2014.
Available
from:
www.who.int/mediacentre/factsheets/fs331/en/
6.
Musher DM, Anna R. Thorner. Community-Acquired Pneumonia. The New
England Journal Of Medicine. 2014: 371; 17
7.
File TM. Community-Acquired Pneumonia. Lancet. 2003: 362; 1991
8.
Brown JS. Community-Acquired Pneumonia. Clinical Medicine 2012, Vol
12, No 6: 538–543
9.
Dharmadhikari V, Joseph T, Kulkarni A. Bacteriological and Clinical Profile
of Community Acquired Pneumonia in Hospitalized Patients. International
Journal of Pharma and Bio Sciences. 2013: 695–702
10. Farida H, Juliëtte A. Severin, M. Gasem MH, et al. Nasopharyngeal Carriage
of Klebsiella pneumoniae and Other Gram-Negative Bacilli in PneumoniaProne Age Groups in Semarang, Indonesia. Journal of Clinical Microbiology.
2013: 1614–1616
11. Lim WS, Eerden MM, Laing R, et al. Defining community acquired
pneumonia severity on presentation to hospital: an international derivation
and validation study. Thorax. 2003; 58: 377–382
48
49
12. Lawrence MT, McPhee JS, Papadakis AM. Diagnosis dan Terapi Kedokteran
Penyakit Dalam. 1 ed. Jakarta: Salemba Medika; 2002. 100 - 10 p
13. Armitage K, Woodhead M. New guidelines for the management of adult
community-acquired pneumonia. Current opinion in infectious diseases.
2007; 20(2): 170-6
14. Dahlan Z. Chapter Pneumonia in Buku Ajar Penyakit Dalam jilid II Edisi IV.
Jakarta: Interna Publishing: 2014. 1608-1619
15. WHO.
Pneumonia.
2014.
Available
from:
who.int/mediacentre/factsheets/fs310/en/
16. Mendel LA, Wuderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC,
Dowell SF, et al. Infectious Disease Society Of America / American Thoracic
Society Consensus Guidelines On The Management Of Community-Acquired
Pneumonia In Adults. Clinical Infectious Disease. 2007; 44: 527-72
17. Ewig S, Welte T. Evaluation of guidelines for community-acquired
pneumonia: a story of confounders, surprises and challenges. Eur Respir J.
2008; 32: 823-5
18. Rabbat A, Huchon GJ. Bacterial Pneumonia. Dalam: Albert RK, Spiro SG,
Jett JR, Clinical Respiratory Medicine, second edition. Ontario: Mosby. 2004;
23: 273-287
19. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C.
Infectious Diseases Society of America. Update of practice guidelines for the
management of community-acquired pneumonia in immunocompetent adults.
Clin Infect Dis. 2003; 37: 1405-1433
20. CDC. The Pink Book: Course Textbook - 12th Edition Second Printing. May
2012. Available from: cdc.gov/vaccines/pubs/pinkbook/pneumo.html
21. Lim WS, Macfarlane JT, Boswell TCJ, Harrison TG, Rose D, Leinonen M,
Saikku P. Study of community acquired pneumonia aetiology (SCAPA) in
adults admitted to hospital: implication for management guidelines. Thorax
2001; 56: 296 – 301
50
22. Sharpe BA, Flanders SA. Community Acquired Pneumonia: A practical
approach to management for hospital. Journal of Hospital Medicine vol 1, no
3. 2006; 177-190
23. Mandell LA. Pneumonia, In : Fauci AS, Kasper DL, Longo DL, eds,
Harrison’s Principles of Internal Medicine, 17th ed, USA, The Mc Graw- Hill
companies Inc. 2008; chapter 251
24. Sharma S, Maycher Bruce, Eschun Gregg. Radiological Imaging in
Pneumonia. Recent Innovations Imaging of Bacterial Pneumonia; 2014.
Available from: medscape.org/viewarticle/556344_2
25. Boersma WG, Daniels J, Löwenberg A, Boeve W-J, van de Jagt EJ.
Reliability of radiographic findings and the relation to etiologic agents in
community-acquired pneumonia. Respiratory medicine. 2006; 100(5): 92632
26. Mandell LA, Wunderink R. Pneumonia. Harrison's Principles of Internal
Medicine. 2. 18th Edition ed. Jakarta: Penerbit Buku Kedokteran EGC. 2006.
957 – 90 p
27. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al.
A prediction rule to identify low-risk patients with community-acquired
pneumonia.N Engl J Med 1997; 336: 243–50
28. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell
GD, et al; American Thoracic Society. Guidelines for the management of
adults with community-acquired pneumonia: Diagnosis, assessment of
severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med.
2001; 163: 1730-1754.
29. Blot SI, Rodriguez A, Solé-Violán, J, Blanquer J, Almirall J, and Rello J.
Effects of delayed oxygenation assessment on time to antibiotic delivery and
mortality in patients with severe community-acquired pneumonia. Crit Care
Med 2007; 35: 2509–2514
30. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al.
BTS guidelines for the management of community acquired pneumonia in
51
adults: update 2009. Thorax 2009; 64: iii1- iii55 doi: 10.1136/thx. 2009.
121434
31. Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in communityacquired pneumonia. Mineola. American Journal of Nephrology. 2007;
27(2):184-190
32. Prasad R. Community Acquired Pneumonia: Clinical Manifestations. Uttar
Pradesh. Supplement to JAPI 2012 VOL. 60: 10
33. Yamakawa S, et al. Recurrent Pneumonia with Unconsciousness. Yokohama,
Japan. Journal of Internal Medicine 2002; 251: 278-279
34. Wyss M, Daouk RK. Creatine and Creatinine Metabolism. Massachusetts.
Physiological Reviews Vol. 80, No. 3, July 2000: 1114
35. Khan FY, Sayed H. Rhabdomyolysis associated with Mycoplasma
pneumoniae pneumonia. Doha, Qatar. Hong Kong Med J Vol 18 No 3, June
2012: 247-248
36. Blanco RJ, Zabalza M, Salcedo J, Roman SJ. Rhabdomyolysis as a results of
Streptococcus pneumoniae: report of a case and review. Spain. European
Society of Clinical Microbiology and Infectious Diseases 2003 : 944-947
37. Mortron SE, Mathai M, Byrd RP, Fields CL, Toy TM. Influenza a Pneumonia
with Rhabdomyolysis. Johnson City. South Med J. 2001; 94 (1)
38. Garcia MC, Ebeo CT, Byrd RP Jr, Roy TM. Rhabdomyolysis associated with
pneumococcal pneumonia: an early clinical indicator of increased morbidity?.
Mountain Home. Tenn Med 2002 Feb; 95(2): 67-9.
39. Ali A, El S, Sikka P, Ramadan F, Davies J. Etiology of Severe Pneumonia in
the Very Elderly. American Journal of Respiratory and Critical Care
Medicine, Vol. 163, No. 3 (2001), pp. 645-651
52
LAMPIRAN
Lampiran 1. Biodata Penulis
1. Identitas
Nama
: Stefanus Christian Setiawan
NIM
: 22010111120009
Tempat/tanggal lahir : Semarang, 18 Desember 1993
Jenis kelamin
: Laki-Laki
Alamat
: Jl. Kenconowungu 6 / 37, Semarang
Nomor HP
: 081227007702
: stchristians@yahoo.com
2. Riwayat Pendidikan Formal
1. SD
: SD YSKI
Lulus tahun
: 2005
2. SMP
: SMP Domenico Savio
Lulus Tahun
: 2008
3. SMA
: SMA Karangturi
Lulus Tahun
: 2011
4. FK UNDIP
: Masuk Tahun 2011
3. Keanggotaan Organisasi
1. Sie. Perkap Porseni FK UNDIP 2013
2. Sie. P&K PMKK FK UNDIP 2011-2012
3. Wakil Ketua Kemah Bakti FK UNDIP 2014
53
Lampiran 2. Ethical Clearance
54
Lampiran 3. Kuisioner CAPSIN
55
Lampiran 4. Analisis Data SPSS
Crosstabs
Jenis kelamin * Outcome
Crosstab
Jenis kelamin
P
W
Total
Count
% within Jenis kelamin
Count
% within Jenis kelamin
Count
% within Jenis kelamin
Outcome
Mati
Sembuh
17
43
28.3%
71.7%
21
52
28.8%
71.2%
38
95
28.6%
71.4%
Usia * Outcome
Crosstab
Usia
15-24
25-34
35-44
45-54
55-64
>= 65
Total
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Count
% within Usia
Outcome
Mati
Sembuh
0
10
.0%
100.0%
3
5
37.5%
62.5%
4
14
22.2%
77.8%
7
15
31.8%
68.2%
11
18
37.9%
62.1%
13
33
28.3%
71.7%
38
95
28.6%
71.4%
Total
10
100.0%
8
100.0%
18
100.0%
22
100.0%
29
100.0%
46
100.0%
133
100.0%
Total
60
100.0%
73
100.0%
133
100.0%
56
Demam * Outcome
Crosstab
Demam
Ya
Tidak
Total
Outcome
Mati
Sembuh
34
83
29.1%
70.9%
4
12
25.0%
75.0%
38
95
28.6%
71.4%
Count
% within Demam
Count
% within Demam
Count
% within Demam
Total
117
100.0%
16
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.114b
.002
.116
.113
df
1
1
1
Asymp. Sig.
(2-sided)
.736
.966
.733
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.497
.737
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
4.57.
Risk Estimate
Value
Odds Ratio for
Demam (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.229
.370
4.080
1.162
.475
2.844
.946
.697
1.284
133
57
Sakit kepala * Outcome
Crosstab
Sakit kepala
Ya
Tidak
Total
Outcome
Mati
Sembuh
9
29
23.7%
76.3%
29
66
30.5%
69.5%
38
95
28.6%
71.4%
Count
% within Sakit kepala
Count
% within Sakit kepala
Count
% within Sakit kepala
Total
38
100.0%
95
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.623b
.333
.637
.618
df
1
1
1
Asymp. Sig.
(2-sided)
.430
.564
.425
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.526
.285
.432
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
10.86.
Risk Estimate
Value
Odds Ratio for Sakit
kepala (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.706
.297
1.679
.776
.407
1.481
1.098
.880
1.371
133
58
Chill * Outcome
Crosstab
Chill
Ya
Tidak
Total
Count
% within Chill
Count
% within Chill
Count
% within Chill
Outcome
Mati
Sembuh
7
21
25.0%
75.0%
31
74
29.5%
70.5%
38
95
28.6%
71.4%
Total
28
100.0%
105
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.222b
.055
.226
.220
df
1
1
1
Asymp. Sig.
(2-sided)
.638
.814
.634
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.814
.415
.639
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
8.00.
Risk Estimate
Value
Odds Ratio for Chill
(Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.796
.307
2.063
.847
.418
1.716
1.064
.831
1.362
133
59
Batuk * Outcome
Crosstab
Batuk
Ya
Tidak
Total
Outcome
Mati
Sembuh
36
89
28.8%
71.2%
2
6
25.0%
75.0%
38
95
28.6%
71.4%
Count
% within Batuk
Count
% within Batuk
Count
% within Batuk
Total
125
100.0%
8
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.053b
.000
.055
.053
df
1
1
1
Asymp. Sig.
(2-sided)
.818
1.000
.815
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.588
.818
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
2.29.
Risk Estimate
Value
Odds Ratio for
Batuk (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.213
.234
6.296
1.152
.336
3.947
.949
.627
1.438
133
60
Sputum * Outcome
Crosstab
Sputum
Ya
Tidak
Total
Count
% within Sputum
Count
% within Sputum
Count
% within Sputum
Outcome
Mati
Sembuh
25
66
27.5%
72.5%
13
29
31.0%
69.0%
38
95
28.6%
71.4%
Total
91
100.0%
42
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.171b
.043
.169
.169
df
1
1
1
Asymp. Sig.
(2-sided)
.680
.836
.681
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.685
.414
.681
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
12.00.
Risk Estimate
Value
Odds Ratio for
Sputum (Ya / Tidak)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.845
.380
1.880
.888
.506
1.556
1.050
.827
1.334
133
61
Hemoptysis * Outcome
Crosstab
Hemoptysis
Ya
Tidak
Total
Outcome
Mati
Sembuh
0
12
.0%
100.0%
38
83
31.4%
68.6%
38
95
28.6%
71.4%
Count
% within Hemoptysis
Count
% within Hemoptysis
Count
% within Hemoptysis
Total
12
100.0%
121
100.0%
133
100.0%
Chi-Square Tests
Value
5.276 b
3.849
8.542
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
5.236
df
1
1
1
Asymp. Sig.
(2-sided)
.022
.050
.003
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.019
.014
.022
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
3.43.
Risk Estimate
Value
For cohort Outcome
= Sembuh
N of Valid Cases
Dyspnea * Outcome
1.458
133
95% Confidence
Interval
Lower
Upper
1.292
1.645
62
Crosstab
Dyspnea
Ya
Outcome
Mati
Sembuh
38
80
32.2%
67.8%
0
15
.0%
100.0%
38
95
28.6%
71.4%
Count
% within Dyspnea
Count
% within Dyspnea
Count
% within Dyspnea
Tidak
Total
Total
118
100.0%
15
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
6.763 b
5.277
10.839
df
1
1
1
6.712
Asymp. Sig.
(2-sided)
.009
.022
.001
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.006
.005
.010
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
4.29.
Risk Estimate
Value
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.678
.599
.768
133
Pleuric pain * Outcome
Crosstab
Pleuric
pain
Ya
Tidak
Total
Count
% within Pleuric pain
Count
% within Pleuric pain
Count
% within Pleuric pain
Outcome
Mati
Sembuh
1
6
14.3%
85.7%
37
89
29.4%
70.6%
38
95
28.6%
71.4%
Total
7
100.0%
126
100.0%
133
100.0%
63
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.739b
.185
.840
df
1
1
1
.733
Asymp. Sig.
(2-sided)
.390
.667
.359
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.673
.354
.392
133
a. Computed only for a 2x2 table
b. 1 cells (25.0%) have expected count less than 5. The minimum expected count is
2.00.
Risk Estimate
Value
Odds Ratio for Pleuric
pain (Ya / Tidak)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.401
.047
3.447
.486
.078
3.047
1.213
.879
1.676
133
Penurunan kesadaran * Outcome
Crosstab
Penurunan
kesadaran
Ya
Tidak
Total
Count
% within Penurunan
kesadaran
Count
% within Penurunan
kesadaran
Count
% within Penurunan
kesadaran
Outcome
Mati
Sembuh
17
10
Total
27
63.0%
37.0%
100.0%
21
85
106
19.8%
80.2%
100.0%
38
95
133
28.6%
71.4%
100.0%
64
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
19.634b
17.576
18.017
df
1
1
1
19.486
1
Asymp. Sig.
(2-sided)
.000
.000
.000
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.000
.000
.000
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
7.71.
Risk Estimate
Value
Odds Ratio for
Penurunan kesadaran
(Ya / Tidak)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
6.881
2.754
17.190
3.178
1.967
5.136
.462
.280
.762
133
Profil klinik * Outcome
Crosstab
Profil
klinik
1-3
4-6
6-9
Total
Count
% within Profil klinik
Count
% within Profil klinik
Count
% within Profil klinik
Count
% within Profil klinik
Outcome
Mati
Sembuh
7
25
21.9%
78.1%
31
68
31.3%
68.7%
0
2
.0%
100.0%
38
95
28.6%
71.4%
Total
32
100.0%
99
100.0%
2
100.0%
133
100.0%
65
Chi-Square Tests
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value
1.868 a
2.446
2
2
Asymp. Sig.
(2-sided)
.393
.294
1
.507
df
.441
133
a. 2 cells (33.3%) have expected count less than 5. The
minimum expected count is .57.
Hemoglobin * Outcome
Crosstab
Hemoglobin
Tidak
Normal
Total
Count
% within Hemoglobin
Count
% within Hemoglobin
Count
% within Hemoglobin
Outcome
Mati
Sembuh
25
66
27.5%
72.5%
13
29
31.0%
69.0%
38
95
28.6%
71.4%
Total
91
100.0%
42
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.171b
.043
.169
.169
df
1
1
1
1
Asymp. Sig.
(2-sided)
.680
.836
.681
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.685
.414
.681
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
12.00.
66
Risk Estimate
Value
Odds Ratio for
Hemoglobin (Tidak /
Normal)
For cohort Outcome
= Mati
For cohort Outcome
= Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.845
.380
1.880
.888
.506
1.556
1.050
.827
1.334
133
Hematokrit * Outcome
Crosstab
Hematokrit
Tidak
Normal
Total
Outcome
Mati
Sembuh
24
61
28.2%
71.8%
14
34
29.2%
70.8%
38
95
28.6%
71.4%
Count
% within Hematokrit
Count
% within Hematokrit
Count
% within Hematokrit
Total
85
100.0%
48
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.013b
.000
.013
.013
df
1
1
1
1
Asymp. Sig.
(2-sided)
.909
1.000
.909
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.531
.909
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.71.
67
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Hematokrit
(Tidak / Normal)
For cohort Outcome = Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.956
.437
2.087
.968
.555
1.688
1.013
.809
1.269
133
Eritrosit * Outcome
Crosstab
Eritrosit
Tidak
Normal
Total
Outcome
Mati
Sembuh
18
54
25.0%
75.0%
20
33
37.7%
62.3%
38
87
30.4%
69.6%
Count
% within Eritrosit
Count
% within Eritrosit
Count
% within Eritrosit
Total
72
100.0%
53
100.0%
125
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
2.340 b
1.777
2.325
2.322
df
1
1
1
1
Asymp. Sig.
(2-sided)
.126
.183
.127
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.168
.092
.128
125
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
16.11.
68
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Eritrosit
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.550
.255
1.188
.663
.390
1.124
1.205
.940
1.544
125
Lekosit * Outcome
Crosstab
Lekosit
Tidak
Normal
Total
Outcome
Mati
Sembuh
26
67
28.0%
72.0%
12
28
30.0%
70.0%
38
95
28.6%
71.4%
Count
% within Lekosit
Count
% within Lekosit
Count
% within Lekosit
Total
93
100.0%
40
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.057b
.001
.057
.057
df
1
1
1
1
Asymp. Sig.
(2-sided)
.811
.976
.811
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.836
.483
.812
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
11.43.
69
Risk Estimate
Value
Odds Ratio for Lekosit
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.905
.401
2.043
.932
.524
1.656
1.029
.810
1.307
133
Trombosit * Outcome
Crosstab
Trombosit
Tidak
Normal
Total
Outcome
Mati
Sembuh
20
44
31.3%
68.8%
18
51
26.1%
73.9%
38
95
28.6%
71.4%
Count
% within Trombosit
Count
% within Trombosit
Count
% within Trombosit
Total
64
100.0%
69
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.434b
.218
.434
.430
df
1
1
1
1
Asymp. Sig.
(2-sided)
.510
.641
.510
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.567
.320
.512
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
18.29.
70
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Trombosit
(Tidak / Normal)
For cohort Outcome = Mati
1.288
.606
2.737
1.198
.699
2.052
.930
.749
1.155
For cohort Outcome =
Sembuh
N of Valid Cases
133
Ureum * Outcome
Crosstab
Ureum
Tidak
Normal
Total
Outcome
Mati
Sembuh
28
57
32.9%
67.1%
10
38
20.8%
79.2%
38
95
28.6%
71.4%
Count
% within Ureum
Count
% within Ureum
Count
% within Ureum
Total
85
100.0%
48
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
2.204 b
1.650
2.273
2.187
df
1
1
1
1
Asymp. Sig.
(2-sided)
.138
.199
.132
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.164
.098
.139
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.71.
71
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Ureum
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
1.867
.814
4.283
1.581
.843
2.967
.847
.688
1.043
133
Kreatinin * Outcome
Crosstab
Kreatinin
Tidak
Normal
Total
Outcome
Mati
Sembuh
21
26
44.7%
55.3%
17
69
19.8%
80.2%
38
95
28.6%
71.4%
Count
% within Kreatinin
Count
% within Kreatinin
Count
% within Kreatinin
Total
47
100.0%
86
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
9.243 b
8.062
9.005
9.173
df
1
1
1
1
Asymp. Sig.
(2-sided)
.002
.005
.003
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.004
.002
.002
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
13.43.
72
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Kreatinin
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
3.278
1.499
7.169
2.260
1.328
3.846
.689
.522
.910
133
GD sewaktu * Outcome
Crosstab
GD sewaktu
Tidak
Normal
Total
Count
% within GD sewaktu
Count
% within GD sewaktu
Count
% within GD sewaktu
Outcome
Mati
Sembuh
12
38
24.0%
76.0%
26
57
31.3%
68.7%
38
95
28.6%
71.4%
Total
50
100.0%
83
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.820b
.501
.833
.814
df
1
1
1
1
Asymp. Sig.
(2-sided)
.365
.479
.361
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.431
.241
.367
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
14.29.
73
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for GD
sewaktu (Tidak / Normal)
For cohort Outcome = Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.692
.312
1.537
.766
.426
1.378
1.107
.894
1.369
133
Natrium * Outcome
Crosstab
Natrium
Tidak
Normal
Total
Outcome
Mati
Sembuh
21
46
31.3%
68.7%
17
49
25.8%
74.2%
38
95
28.6%
71.4%
Count
% within Natrium
Count
% within Natrium
Count
% within Natrium
Total
67
100.0%
66
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.508b
.271
.509
.504
df
1
1
1
1
Asymp. Sig.
(2-sided)
.476
.602
.476
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.566
.301
.478
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
18.86.
74
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Natrium
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
1.316
.618
2.801
1.217
.708
2.092
.925
.746
1.147
133
Kalium * Outcome
Crosstab
Kalium
Tidak
Normal
Total
Outcome
Mati
Sembuh
13
42
23.6%
76.4%
25
53
32.1%
67.9%
38
95
28.6%
71.4%
Count
% within Kalium
Count
% within Kalium
Count
% within Kalium
Total
55
100.0%
78
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
1.119 b
.745
1.134
1.111
df
1
1
1
1
Asymp. Sig.
(2-sided)
.290
.388
.287
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.333
.195
.292
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
15.71.
75
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Kalium
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
.656
.300
1.436
.737
.415
1.310
1.124
.909
1.389
133
Khlorida * Outcome
Crosstab
Khlorida
Tidak
Normal
Total
Outcome
Mati
Sembuh
21
32
39.6%
60.4%
17
63
21.3%
78.8%
38
95
28.6%
71.4%
Count
% within Khlorida
Count
% within Khlorida
Count
% within Khlorida
Total
53
100.0%
80
100.0%
133
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
5.273 b
4.411
5.206
5.233
df
1
1
1
1
Asymp. Sig.
(2-sided)
.022
.036
.023
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.031
.018
.022
133
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
15.14.
76
Risk Estimate
95% Confidence
Interval
Lower
Upper
Value
Odds Ratio for Khlorida
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
2.432
1.128
5.242
1.865
1.090
3.190
.767
.599
.981
133
Kalsium * Outcome
Crosstab
Kalsium
Tidak
Normal
Total
Outcome
Mati
Sembuh
16
41
28.1%
71.9%
15
34
30.6%
69.4%
31
75
29.2%
70.8%
Count
% within Kalsium
Count
% within Kalsium
Count
% within Kalsium
Total
57
100.0%
49
100.0%
106
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value
.082b
.005
.082
.082
df
1
1
1
1
Asymp. Sig.
(2-sided)
.774
.942
.774
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.832
.470
.775
106
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is
14.33.
77
Risk Estimate
Value
Odds Ratio for Kalsium
(Tidak / Normal)
For cohort Outcome =
Mati
For cohort Outcome =
Sembuh
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.885
.382
2.046
.917
.507
1.657
1.037
.810
1.327
106
Logistic Regression
Case Processing Summary
Unweighted Cases
Selected Cases
Unselected Cases
Total
a
N
Included in Analysis
Missing Cases
Total
133
0
133
0
133
Percent
100.0
.0
100.0
.0
100.0
a. If weight is in effect, see classification table for the total
number of cases.
78
Dependent Variable Encoding
Original Value
Sembuh
Mati
Internal Value
0
1
Categorical Variables Codings
Khlorida
Dyspnea
Penurunan
kesadaran
Kreatinin
Hemoptysis
Tidak
Normal
Ya
Tidak
Ya
Tidak
Tidak
Normal
Ya
Tidak
Paramete
r coding
(1)
Frequency
53
80
118
15
27
106
47
86
12
121
.000
1.000
.000
1.000
.000
1.000
.000
1.000
.000
1.000
Block 0: Beginning Block
Classification Tablea,b
Predicted
Step 0
Observed
Outcome
Sembuh
Mati
Outcome
Sembuh
Mati
95
0
38
0
Overall Percentage
Percentage
Correct
100.0
.0
71.4
a. Constant is included in the model.
b. The cut value is .500
Variables in the Equation
Step 0
Constant
B
-.916
S.E.
.192
Wald
22.789
df
1
Sig.
.000
Exp(B)
.400
79
Variables not in the Equation
Step
0
Variables
Score
5.276
6.763
19.634
9.243
5.273
33.940
HEMOP(1)
DYSP(1)
TK(1)
KREAT(1)
CHLR(1)
Overall Statistics
df
1
1
1
1
1
5
Sig.
.022
.009
.000
.002
.022
.000
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Step 1
Step
Block
Model
Chi-square
41.355
41.355
41.355
df
5
5
5
Sig.
.000
.000
.000
Model Summary
Step
1
-2 Log
likelihood
117.784
Cox & Snell
R Square
.267
Nagelkerke
R Square
.383
Classification Tablea
Predicted
Step 1
Observed
Outcome
Outcome
Sembuh
Mati
88
7
26
12
Sembuh
Mati
Overall Percentage
Percentage
Correct
92.6
31.6
75.2
a. The cut value is .500
Variables in the Equation
Step
a
1
HEMOP(1)
DYSP(1)
TK(1)
KREAT(1)
CHLR(1)
Constant
B
20.094
-20.128
-1.646
-1.106
-.554
-18.511
S.E.
10479.2
9659.54
.522
.459
.457
10479.2
Wald
.000
.000
9.924
5.810
1.466
.000
df
1
1
1
1
1
1
Sig.
.998
.998
.002
.016
.226
.999
Exp(B)
5.E+08
.000
.193
.331
.575
.000
a. Variable(s) entered on step 1: HEMOP, DYSP, TK, KREAT, CHLR.
95.0% C.I.for
EXP(B)
Lower
Upper
.000
.
.000
.
.069
.537
.135
.813
.235
1.409
80
Logistic Regression
Case Processing Summary
Unweighted Cases
Selected Cases
a
N
Included in Analysis
Missing Cases
Total
133
0
133
0
133
Unselected Cases
Total
Percent
100.0
.0
100.0
.0
100.0
a. If weight is in effect, see classification table for the total
number of cases.
Dependent Variable Encoding
Original Value
Sembuh
Mati
Internal Value
0
1
Categorical Variables Codings
Kreatinin
Penurunan
kesadaran
Tidak
Normal
Ya
Tidak
Frequency
47
86
27
106
Block 0: Beginning Block
Paramete
r coding
(1)
.000
1.000
.000
1.000
81
Classification Tablea,b
Predicted
Step 0
Observed
Outcome
Outcome
Sembuh
Mati
95
0
38
0
Sembuh
Mati
Percentage
Correct
100.0
.0
71.4
Overall Percentage
a. Constant is included in the model.
b. The cut value is .500
Variables in the Equation
Step 0
B
-.916
Constant
S.E.
.192
Wald
22.789
df
1
Sig.
.000
1
1
2
Sig.
.000
.002
.000
Exp(B)
.400
Variables not in the Equation
Step
0
Variables
Score
19.634
9.243
24.938
TK(1)
KREAT(1)
Overall Statistics
df
Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Step 1
Step
Block
Model
Chi-square
23.951
23.951
23.951
df
2
2
2
Sig.
.000
.000
.000
Model Summary
Step
1
-2 Log
likelihood
135.188
Cox & Snell
R Square
.165
Nagelkerke
R Square
.236
Classification Tablea
Predicted
Step 1
Observed
Outcome
Overall Percentage
a. The cut value is .500
Sembuh
Mati
Outcome
Sembuh
Mati
85
10
21
17
Percentage
Correct
89.5
44.7
76.7
82
Variables in the Equation
Step
a
1
TK(1)
KREAT(1)
Constant
B
-1.818
-1.042
1.068
S.E.
.481
.428
.474
Wald
14.306
5.918
5.077
a. Variable(s) entered on step 1: TK, KREAT.
df
1
1
1
Sig.
.000
.015
.024
Exp(B)
.162
.353
2.908
95.0% C.I.for EXP(B)
Lower
Upper
.063
.416
.152
.817